abt 702 has been researched along with formaldehyde in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhagwat, SS; Cox, BF; Gomtsyan, A; Jarvis, MF; Jiang, M; Kowaluk, EA; Lee, CH; Lynch, JJ; McKie, J; Mikusa, J; Polakowski, J; Reinhart, G; Schweitzer, E; Williams, M; Wismer, CT; Zhu, CZ | 1 |
| Bhagwat, SS; Cowart, M; Gfesser, G; Gu, YG; Jarvis, MF; Jiang, M; Kim, KH; Kowaluk, EA; Lee, CH; Perner, R; Stewart, AO; Williams, M | 1 |
2 other study(ies) available for abt 702 and formaldehyde
| Article | Year |
|---|---|
ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat.
Topics: Adenosine Kinase; Administration, Oral; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diabetes Mellitus, Experimental; Edema; Enzyme Inhibitors; Formaldehyde; Hemodynamics; Hyperalgesia; Male; Morpholines; Motor Activity; Pain; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Streptozocin | 2000 |
Discovery of 4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine, an orally active, non-nucleoside adenosine kinase inhibitor..
Topics: Adenosine Kinase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Drug Design; Enzyme Inhibitors; Formaldehyde; Humans; Models, Molecular; Molecular Conformation; Morpholines; Pain Measurement; Pyrimidines; Rats; Tumor Cells, Cultured | 2001 |